UNSPSC 51282519: Cefacetrile sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C13H12N3O6S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 87TH1FJY1N, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-cyanoacetamido)-3-(hydroxymethyl)-8-oxo-, acetate (ester), monosodium salt but more generally known as cefacetrile sodium, which bears US NIH Compound Identifier 31725.

European Medicines Agency schedules Cefacetrile sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01094MIG. Most nations, for tariff and trade purposes, schedule cefacetrile sodium under HS 29419000. SMILES: CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC#N)SC1)C(=O)[O-].[NA+].

UNSPSC 51282519 Cefacetrile sodium is a Commodity code that identifies a specific antibiotic pharmaceutical product. However, the recent state and local opportunities posted under this code show no active solicitations for cefacetrile sodium itself. The Illinois Department of Public Health awarded a completed piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride — neither of which is cefacetrile sodium — totaling $2,999,999.11 over a three-year term with an initial 12-month period. A second opportunity from Seminole County, Florida posted in June 2026 sought Naloxone and Safe Drug Deactivation Systems annually, also unrelated to the coded commodity. The code shows a significant mismatch between its nominal scope and the work actually being tagged to it in recent state and local procurement activity.

The absence of relevant recent solicitations for cefacetrile sodium suggests minimal current state and local demand for this specific antibiotic under the code, or systematic misclassification of pharmaceutical procurements in the available records. Procurement teams pursuing this code should verify whether state and local health departments, pharmacy benefit managers, and institutional healthcare systems are actively tendering cefacetrile sodium through RFP, RFQ, or IFB channels, as the current record does not support active opportunity flow under the coded commodity.